Discover the effectiveness of sonic sleep aids, revealing which audio tools truly enhance sleep quality and which may not deliver on their promises.

Existing medications for narcolepsy aim for symptom control. But therapies in development are targeting the specific mechanism of the disease and the brain’s natural sleep-wake cycle.

A recent study reveals ustekinumab outperforms adalimumab and secukinumab in drug survival for psoriasis, guiding treatment decisions for patients.

Five experimental drugs show promise in significantly lowering lipoprotein(a). The furthest along is pelacarsen, with phase 3 results expected in the first half of this year, and regulatory filings in the second half of this year.

A nationwide randomized study showed that risk-based breast cancer screening safely detects cancer while reducing unnecessary screening for low-risk women and is favored by most patients over annual mammograms.

In a wide-ranging interview, Mitchell discussed the Purchaser Business Group Health’s health data demonstration project, employer fiduciary responsibility, consequences of the end of enhanced Affordable Care Act subsidies and direct contracting.

Shekhar Khera, senior vice president, product management at RxBenefits, discusses the role of artificial intelligence in healthcare and how his company is using it to improve efficiency, outcomes and the member experience.

The PBM association also appointed Brendan Buck chief communications officer. Both Marin and Buck begin Jan. 20, 2026.

Independence Blue Cross announces three out of five 2026 Clinical Care Innovation Grants to enhance healthcare access and outcomes through innovative projects by leading health systems.